John N. Bonfiglio

Plus aucun poste en cours

Profil

John N.
Bonfiglio formerly worked at Orchestra Therapeutics, Inc., as President & Chief Executive Officer from 2003 to 2005, Oragenics, Inc., as President, Chief Executive Officer & Director from 2011 to 2014, Argos Therapeutics, Inc., as President & Chief Executive Officer, Harrow, Inc., as President, Chief Executive Officer & Director from 2010 to 2011, Allergan, Inc., as Director-Business Planning, Baxter Healthcare Corp., as Director-Strategic Business Unit, GT Biopharma, Inc., as Director from 2018 to 2019, Marker Therapeutics, Inc., as President, Chief Operating Officer & Director from 2016 to 2017, Genprex, Inc., as Director in 2019, Microlin Bio, Inc., as Director, Microlin Bio, Inc., as Director, Cypress Bioscience, Inc., as Chief Operating Officer & Executive Vice President, and Qrons, Inc., as Chief Operating Officer in 2019.
Dr. Bonfiglio received his undergraduate degree in 1976 from Stony Brook University, Masters Business Admin degree in 1992 from Pepperdine University, doctorate degree from the University of California, Berkeley, and graduate degree in 1980 and doctorate degree in 1980 from the University of California San Diego.

Anciens postes connus de John N. Bonfiglio

Sociétés	Poste	Fin
QRONS INC.	Directeur des opérations	30/11/2019
GENPREX, INC.	Directeur/Membre du Conseil	10/06/2019
GT BIOPHARMA, INC.	Directeur/Membre du Conseil	20/03/2019
MARKER THERAPEUTICS, INC.	President	27/04/2017
ORAGENICS, INC.	Directeur Général	30/10/2014

Formation de John N. Bonfiglio

Pepperdine University	Masters Business Admin
University of California San Diego	Doctorate Degree
Stony Brook University	Undergraduate Degree
University of California, Berkeley	Doctorate Degree